tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 779 are a BUY (93.74%), 49 are a HOLD (5.9%), 3 are a SELL (0.36%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 28.55% that have a potential upside of 45.83% achieved within 154 days.
Raghuram Selvaraju’s has documented 1,560 price targets and ratings displayed on 96 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ADXN, Addex Therapeutics Ltd at 28-Aug-2024.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $24 was fulfilled within 3 days with a profit of $10.68 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
9 months 11 days ago
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
1
$-0.07 (-6.54%)
5
10 months 6 days ago
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
1
$-0.07 (-6.54%)
3.5
1 years 1 months 12 days ago
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
1.25
$0.18 (16.82%)
2
1 years 1 months 12 days ago
2/5 (40%)
$0.17 (15.74%)
215
Buy
10
2 years 2 months 9 days ago
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
